4-butyrolactone has been researched along with pyrophosphate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Keefe, AD; Miller, SL | 1 |
Chamani, J; Hakimelahi, GH; Hakimelahi, S; Hassanzadeh, F; Jain, ML; Khodarahmi, GA; Kulatheeswaran, R; Luo, FT; Ly, TW; Moosavi-Movahedi, AA; Pasdar, M; Shia, KS; Xue, C; Yen, CF | 1 |
2 other study(ies) available for 4-butyrolactone and pyrophosphate
Article | Year |
---|---|
Potentially prebiotic syntheses of condensed phosphates.
Topics: 4-Butyrolactone; Acetic Anhydrides; Calcium; Diphosphates; Evolution, Chemical; Formaldehyde; Formates; Hydrogen Cyanide; Imidazoles; Magnesium; Maleic Anhydrides; Methenamine; Nitriles; Phosphates; Polyphosphates; Thiocyanates | 1996 |
Design, synthesis, and anticancer activity of phosphonic acid diphosphate derivative of adenine-containing butenolide and its water-soluble derivatives of paclitaxel with high antitumor activity.
Topics: 4-Butyrolactone; Adenine; Animals; Antineoplastic Agents; Cell Division; Cell Line, Tumor; Cell Nucleus; Diphosphates; Drug Design; Drug Screening Assays, Antitumor; Furans; Humans; Microtubules; Organophosphonates; Paclitaxel; Prodrugs; Ribonucleoside Diphosphate Reductase; Solubility; Structure-Activity Relationship | 2003 |